Veracyte, Inc. (VCYT)
NASDAQ·Healthcare·Biotechnology
$51.00
+0.23%
Mkt Cap $3.93B
Analyst Ratings
Buy
7
Hold
2
Sell
1
Price Target (11 analysts)
$44.50
Range $37.00 – $50.00
Implied Upside
-12.7%
Consensus $44.50 vs current $51.00
NASDAQ·Healthcare·Biotechnology
$51.00
+0.23%
Mkt Cap $3.93B
Buy
7
Hold
2
Sell
1
Price Target (11 analysts)
$44.50
Range $37.00 – $50.00
-12.7%
Consensus $44.50 vs current $51.00